The Apoptotic, Cytotoxic, and Antiangiogenic Impact of Linum usitatissimum Seed Essential Oil Nanoemulsions on the Human Ovarian Cancer Cell Line A2780.

BACKGROUND: Linum usitatissimum seed essential oil (LSEO) has been used to reduce the risk of prostate and colon cancer. In this study, we optimized the bio-accessibility and bio-compatibility of LSEO to evaluate its cytotoxic, apoptotic and anti-angiogenic impact on the human ovarian cancer cell line A2780. METHOD: We produced LSEO nanoemulsions (LSEO-NEs) utilizing the ultrasound-based technique and the size, its droplets' morphology and stability were characterized. LSEO-NE cytotoxicity was studied by estimating the viability of A2780 human ovarian cancer cell and normal human foreskin fibroblasts (HFFS). Their apoptotic activity was evaluated measuring the Caspase-3, 8 and nine gene expression. Finally, its anti-angiogenic potential was measured applying Chick Chorioallantoic Membrane (CAM) assay. RESULTS: A significant dose-dependent cytotoxic impact of LSEO-NE was detected in the A2780 cells and not in HFF cellsThe apoptotic genes expression profile confirmed the A2780 cell apoptosis death. Moreover, the reduction in length and number of blood vessels in the CAM assay demonstrated the anti-angiogenic activity of LSEO-NE. CONCLUSION: The cancer cell-selective cytotoxicity apoptosis, and anti-angiogenic effects of LSEO-NE indicate its potential as a novel anticancer compound. However, further cell lines have to be analyzed in case of its potential anticancer impacts on human ovarian cancer cells.

Citrus lemon essential oil nanoemulsion (CLEO-NE), a safe cell-depended apoptosis inducer in human A549 lung cancer cells with anti-angiogenic activity.

Aims: Citrus lemon essential oil (CLEO) has been introduced as a strong antioxidant mixture. However, it is not efficient enough due to its hydrophobic nature. Nanoemulsions improve the drugs' bio-compatibility in aqueous conditions.Methods: The CLEO nanoemulsion (CLEO-NE) was formulated by ultrasound-based-emulsification and they were characterised. The anti-angiogenic and antioxidant activities were studied by the chicken chorioallantoic membrane (CAM) and antioxidant (ABTS and DPPH) assays, respectively. Finally, the apoptotic property of CLEO-NE on both HFF and A549 was evaluated by [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) assay and real time-PCR (measuring Cas-3 gene expression).Results: The 30.2-nm CLEO-NE droplets significantly increased Cas-3 in A549 cells and decreased angiogenesis in chick embryo chorioallantoic membrane (p < 0.01).Conclusion: In conclusion, CLEO-NE has the potential to be used as a safe cell-depended anticancer agent for human lung cancer. However, further genes and cell lines have to be studied to clarify its targeted-anticancer activity.

Synthesis of Carum Carvi essential oil nanoemulsion, the cytotoxic effect, and expression of caspase 3 gene.

Scientists are attempting to find novel methods to overcome cancers. Nanoemulsion systems as the novel drug delivery tools have been widely used in cancer therapy. In this study, the Carum Carvi oil nanoemulsions (CCONE) were prepared and its cytotoxic activity was studied on human colon cancer HT-29 cells using MTT assay. Flow cytometry and Real-time qPCR were triggered to evaluate the nanoemulsions' apoptotic properties. The results showed a significant negative association between the HT-29 cancer cell viability and CCONE doses of treatments compared with Huvec normal cells (p value < 0.001). The IC50 values were estimated 12.5 µg/ml and 50 µg/ml for HT-29 and Huvec, respectively. Moreover, we observed that increasing concentrations of nanoemulsions significantly upregulate Caspase-3 gene expression. The results showed the CCONE is an efficient novel apoptosis inducer for human colon cancer cells without any undesirable side effects. However, further in vitro and in vivo researches are required. PRACTICAL APPLICATIONS: Cancer is a complex and usually untreatable disorder. Several types of cancer therapy strategies have been applied widely to overcome cancers. Chemotherapy has been used in various types of cancers. In most cases, not only it had not been effective on cancer cells but also been distractive within normal tissues. According to results, Carum Carvi essential oil nanoemulsions have apoptotic and cytotoxic effects on colon cancer cells (HT-29). When it comes to cancer of any kind, it's important to realize that no dietary supplement can fully treat, cure, or prevent cancer. However, there are some supplements that can potentially decrease the risk of cancer. Nanoemulsions present several advantages including the ability to incorporate hydrophilic, amphiphilic, and lipophilic excipient ingredients, high physical stability, and rapid gastrointestinal digestibility. The Carum Carvi essential oil nanoemulsion can also be applied as an effective food supplement due to its potent apoptotic activity.

Green synthesis of silver nanoparticles using Rubia tinctorum extract and evaluation the anti-cancer properties in vitro.

Cancer is one of the leading causes of human death. Nanotechnology could offer new and optimised anticancer agents in order to fight cancer. It was shown that metal nanoparticles, in particular silver nanoparticles (AgNPs) were effective in cancer therapy. In this study, AgNPs were synthesised using Rubia tinctorum L. extract (Ru-AgNPs). Then, cytotoxicity effects of the Ru-AgNPs against MDA-MB-231 carcinoma cell line and human dermal fibroblast as normal cell line were performed. Furthermore, anti-apoptotic effects of Ru-AgNPs on these cancer and normal cell lines were compared using acridine orange/propidium iodide staining, flow cytometry analysis and real-time qPCR in apoptosis gene markers. Results of UV-vis spectroscopy showed that Ru-AgNPs have a peak at 430 nm, which indicated synthesis of AgNPs. Ru-AgNPs had spherical shape and average size of 12 nm. Ru-AgNPs have cytotoxicity on MDA-MB-231 cells and decrease cancerous cell viability (IC50 = 4 µg/ml/48 h). Ru-AgNPs could induce apoptosis in MDA-MB-231 cells through upregulation of Bax and downregulation of Bcl-2 gene expression. The results opened up new avenues to develop Rubia based metal complexes as an anticancer agent.